Invitrogen™ HRASLS3 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA567562

Catalog No. PIPA567562

Description

HRASLS3 Polyclonal Antibody for IHC (P)

HRASLS3 specifically catalyzes the release of fatty acids from phospholipids in adipose tissue. It also has a weak lysophospholipase activity. Tumor suppressor that may be involved in interferon-dependent cell death.

Specifications

• Antigen: HRASLS3
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: PLAAT3
• Gene Alias: Adipose-specific phospholipase A2; adipose-specific PLA2; AdPLA; C78643; Ca-independent phospholipase A1/2; group XVI phospholipase A1/A2; Group XVI phospholipase A2; HRAS like suppressor 3; HRAS-like suppressor 1; HRAS-like suppressor 3; HRASLS3; H-rev 107 protein; H-rev 107 protein homolog; Hrev107; H-REV107; H-REV107-1; HREV107-1; HREV107-3; HRSL3; LRAT-like protein 3; MLP-3; Phospholipase A and acyltransferase 3; phospholipase A2 group XVI; phospholipase A2, group XVI; Pla2g16; PLAAT3; Renal carcinoma antigen NY-REN-65
• Host Species: Rabbit
• Purification Method: affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 11145
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin)
• Concentration: 1.5 mg/mL
• Formulation: PBS with 40% glycerol and 0.05% sodium azide; pH 7.4
• Gene Accession No.: P53816
• Gene Symbols: PLAAT3
• Immunogen: Synthesized peptide derived from human HRASLS3.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG